Literature DB >> 15837576

Basement membrane fragility underlies embryonic lethality in fukutin-null mice.

Hiroki Kurahashi1, Mariko Taniguchi, Chikara Meno, Yoshihiro Taniguchi, Satoshi Takeda, Masato Horie, Hiroki Otani, Tatsushi Toda.   

Abstract

Fukuyama-type congenital muscular dystrophy (FCMD), associated with brain malformation due to defects in neuronal migration, is caused by mutations in fukutin. Several lines of evidence suggest that the fukutin protein plays a pivotal role in synthesis of O-mannosyl sugar moieties of alpha-dystroglycan, a cell surface laminin receptor. Here, through targeted disruption of the orthologous mouse fukutin gene, we show that the fukutin protein is essential, as homozygous-null embryos die by E9.5 of gestation. Fukutin-null embryos show phenotypic diversity, features of which include growth retardation, folding of the egg cylinder, leakage of maternal red blood cells into the yolk sac cavity, and an increased number of apoptotic cells in the ectoderm. Loss of immunoreactivity against sugar moieties in alpha-dystroglycan suggests a reduced laminin-binding capacity. Ultrastructural analysis shows thin and breached basement membranes (BMs). BM fragility may underlie all of these abnormal phenotypes, and maintenance of BM function may require fukutin-mediated glycosylation of alpha-dystroglycan early in embryonic development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15837576     DOI: 10.1016/j.nbd.2004.12.018

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  20 in total

1.  A role of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in cancer cells: a possible role to suppress cell proliferation.

Authors:  Tomoko Yamamoto; Yoichiro Kato; Noriyuki Shibata; Tatsuo Sawada; Makiko Osawa; Makio Kobayashi
Journal:  Int J Exp Pathol       Date:  2008-10       Impact factor: 1.925

Review 2.  Swimming into prominence: the zebrafish as a valuable tool for studying human myopathies and muscular dystrophies.

Authors:  Elizabeth M Gibbs; Eric J Horstick; James J Dowling
Journal:  FEBS J       Date:  2013-07-25       Impact factor: 5.542

Review 3.  What do mouse models of muscular dystrophy tell us about the DAPC and its components?

Authors:  Charlotte Whitmore; Jennifer Morgan
Journal:  Int J Exp Pathol       Date:  2014-09-30       Impact factor: 1.925

Review 4.  The genetic and molecular basis of muscular dystrophy: roles of cell-matrix linkage in the pathogenesis.

Authors:  Motoi Kanagawa; Tatsushi Toda
Journal:  J Hum Genet       Date:  2006-09-13       Impact factor: 3.172

5.  Heterozygous deletion of a 2-Mb region including the dystroglycan gene in a patient with mild myopathy, facial hypotonia, oral-motor dyspraxia and white matter abnormalities.

Authors:  Amy R Frost; Sabrina V Böhm; Raj N Sewduth; Dragana Josifova; Caroline Mackie Ogilvie; Louise Izatt; Roland G Roberts
Journal:  Eur J Hum Genet       Date:  2010-03-17       Impact factor: 4.246

6.  Developmental expression of the neuron-specific N-acetylglucosaminyltransferase Vb (GnT-Vb/IX) and identification of its in vivo glycan products in comparison with those of its paralog, GnT-V.

Authors:  Jin Kyu Lee; Russell T Matthews; Jae-Min Lim; Kiara Swanier; Lance Wells; J Michael Pierce
Journal:  J Biol Chem       Date:  2012-06-19       Impact factor: 5.157

7.  Mouse models of fukutin-related protein mutations show a wide range of disease phenotypes.

Authors:  Anthony Blaeser; Elizabeth Keramaris; Yiumo M Chan; Susan Sparks; Dale Cowley; Xiao Xiao; Qi Long Lu
Journal:  Hum Genet       Date:  2013-04-17       Impact factor: 4.132

8.  Mouse fukutin deletion impairs dystroglycan processing and recapitulates muscular dystrophy.

Authors:  Aaron M Beedle; Amy J Turner; Yoshiaki Saito; John D Lueck; Steven J Foltz; Marisa J Fortunato; Patricia M Nienaber; Kevin P Campbell
Journal:  J Clin Invest       Date:  2012-08-27       Impact factor: 14.808

9.  Brain and eye malformations resembling Walker-Warburg syndrome are recapitulated in mice by dystroglycan deletion in the epiblast.

Authors:  Jakob S Satz; Rita Barresi; Madeleine Durbeej; Tobias Willer; Amy Turner; Steven A Moore; Kevin P Campbell
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

Review 10.  Therapeutic possibilities in the autosomal recessive limb-girdle muscular dystrophies.

Authors:  Volker Straub; Kate Bushby
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.